Department of Immunology and Pathology, Monash University, Melbourne, VIC, Australia.
Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia.
Front Immunol. 2018 Mar 1;9:401. doi: 10.3389/fimmu.2018.00401. eCollection 2018.
Systemic lupus erythematosus (SLE) is a progressive autoimmune disease characterized by increased sensitivity to self-antigens, auto-antibody production, and systemic inflammation. B cells have been implicated in disease progression and as such represent an attractive therapeutic target. Lyn is a Src family tyrosine kinase that plays a major role in regulating signaling pathways within B cells as well as other hematopoietic cells. Its role in initiating negative signaling cascades is especially critical as exemplified by Lyn mice developing an SLE-like disease with plasma cell hyperplasia, underscoring the importance of tightly regulating signaling within B cells. This review highlights recent advances in our understanding of the function of the Src family tyrosine kinase Lyn in B lymphocytes and its contribution to positive and negative signaling pathways that are dysregulated in autoimmunity.
系统性红斑狼疮(SLE)是一种进行性自身免疫性疾病,其特征是对自身抗原的敏感性增加、自身抗体产生和全身炎症。B 细胞被认为与疾病进展有关,因此是一个有吸引力的治疗靶点。Lyn 是一种Src 家族酪氨酸激酶,在调节 B 细胞以及其他造血细胞内的信号通路中起着重要作用。它在启动负信号级联反应中的作用尤为关键,例如 Lyn 敲除小鼠会发展出类似 SLE 的疾病,伴有浆细胞增生,这突显了严格调节 B 细胞内信号的重要性。这篇综述强调了我们对 Src 家族酪氨酸激酶 Lyn 在 B 淋巴细胞中的功能及其对自身免疫中失调的正、负信号通路的贡献的最新理解。